目前许多研究已表明原发性肝癌患者血清补体水平升高 ,特别是血清补体Ｃ3 升高更为明显[1] 。但补体Ｃ3 升高的水平与肝癌的病理类型关系如何 ,目前尚不清楚。为此 ,我们探讨了肝癌的大小、大体形态、分化程度等病理类型与肝癌患者的血清Ｃ3 含量的关系。1　资料与方法1 1　一 At present, many studies have shown that the serum complement level is elevated in patients with primary liver cancer, especially the increase of serum complement C3 is more obvious [1]. However, the relationship between the level of complement C3 elevation and the pathological type of liver cancer is still unclear. For this purpose, we investigated the relationship between the pathological types of hepatocellular carcinoma, such as size, gross morphology, and differentiation, and serum C3 levels in patients with liver cancer. 1 Materials and Methods 1 1